This bill directs the Department of Veterans Affairs to provide opioid antagonists (medications like naloxone that reverse opioid overdoses) to veterans without requiring a prescription or charging a copayment. Currently, veterans may face barriers to accessing these life-saving medications through the VA system. The legislation applies to all veterans enrolled in VA care and removes both the prescription requirement and any out-of-pocket costs. No specific funding amount or timeline is specified in the bill text, meaning the VA would provide the medication as part of its existing healthcare operations. The bill was introduced in November 2025 and referred to the House Committee on Veterans' Affairs for consideration.